Cargando…

The Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders

Leukotrienes (LTs) are lipid mediators that play pivotal roles in acute and chronic inflammation and allergic diseases. They exert their biological effects by binding to specific G-protein-coupled receptors. Each LT receptor subtype exhibits unique functions and expression patterns. LTs play roles i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jo-Watanabe, Airi, Okuno, Toshiaki, Yokomizo, Takehiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679143/ https://www.ncbi.nlm.nih.gov/pubmed/31336653 http://dx.doi.org/10.3390/ijms20143580

Ejemplares similares

Biological functions of 12(S)-hydroxyheptadecatrienoic acid as a ligand of leukotriene B(4) receptor 2
por: Okuno, Toshiaki, et al.
Publicado: (2018)

Leukotriene B(4) receptor type 2 protects against pneumolysin-dependent acute lung injury
por: Shigematsu, Misako, et al.
Publicado: (2016)

A Second Leukotriene B(4) Receptor, Blt2: A New Therapeutic Target in Inflammation and Immunological Disorders
por: Yokomizo, Takehiko, et al.
Publicado: (2000)

12(S)-hydroxyheptadeca-5Z, 8E, 10E–trienoic acid is a natural ligand for leukotriene B(4) receptor 2
por: Okuno, Toshiaki, et al.
Publicado: (2008)

Biochemical and immunological characterization of a novel monoclonal antibody against mouse leukotriene B(4) receptor 1
por: Sasaki, Fumiyuki, et al.
Publicado: (2017)

Expression of leukotriene B(4) receptor 1 defines functionally distinct DCs that control allergic skin inflammation
por: Koga, Tomoaki, et al.
Publicado: (2020)

Non-steroidal anti-inflammatory drug delays corneal wound healing by reducing production of 12-hydroxyheptadecatrienoic acid, a ligand for leukotriene B(4) receptor 2
por: Iwamoto, Satoshi, et al.
Publicado: (2017)

Eicosanoids in Skin Wound Healing
por: Yasukawa, Ken, et al.
Publicado: (2020)

Cell-Specific Transcriptional Regulation of Human Leukotriene B(4) Receptor Gene
por: Kato, Kazuhiko, et al.
Publicado: (2000)

Role of Leukotrienes and Leukotriene Modifiers in Asthma
por: Montuschi, Paolo
Publicado: (2010)

Leukotriene B4 as a Potential Therapeutic Target for the Treatment of Metabolic Disorders
por: Filgueiras, Luciano Ribeiro, et al.
Publicado: (2015)

Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis
por: Peters-Golden, M, et al.
Publicado: (2006)

The leukotriene B(4) receptor BLT1 is stabilized by transmembrane helix capping mutations
por: Hori, Tetsuya, et al.
Publicado: (2015)

Dietary ω-3 fatty acids alter the lipid mediator profile and alleviate allergic conjunctivitis without modulating T(h)2 immune responses
por: Hirakata, Toshiaki, et al.
Publicado: (2019)

Biochemical Characterization of Three BLT Receptors in Zebrafish
por: Okuno, Toshiaki, et al.
Publicado: (2015)

Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases
por: Gelosa, Paolo, et al.
Publicado: (2017)

Role of the high-affinity leukotriene B(4) receptor signaling in fibrosis after unilateral ureteral obstruction in mice
por: Kamata, Mariko, et al.
Publicado: (2019)

Role of leukotriene B(4) (LTB(4))-LTB(4) receptor 1 signaling in post-incisional nociceptive sensitization and local inflammation in mice
por: Asahara, Miho, et al.
Publicado: (2022)

Cysteinyl Leukotrienes in Eosinophil Biology: Functional Roles and Therapeutic Perspectives in Eosinophilic Disorders
por: Thompson-Souza, Glaucia A., et al.
Publicado: (2017)

Correction: Role of the high-affinity leukotriene B(4) receptor signaling in fibrosis after unilateral ureteral obstruction in mice
por: Kamata, Mariko, et al.
Publicado: (2019)

Leukotrienes, a potential target for Covid-19
por: Citron, Francesca, et al.
Publicado: (2020)

The absence of the leukotriene B(4) receptor BLT1 attenuates peripheral inflammation and spinal nociceptive processing following intraplantar formalin injury
por: Asahara, Miho, et al.
Publicado: (2015)

Role of Leukotriene B(4) Receptor-2 in Mast Cells in Allergic Airway Inflammation
por: Kwon, Sun-Young, et al.
Publicado: (2019)

Leukotriene Signaling as a Target in α-Synucleinopathies
por: Strempfl, Katharina, et al.
Publicado: (2022)

Role of Leukotrienes on Protozoan and Helminth Infections
por: Rogerio, Alexandre P., et al.
Publicado: (2012)

Managing Co-Morbid Asthma With Allergic Rhinitis: Targeting the One-Airway With Leukotriene Receptor Antagonists
por: Valovirta, Erkka
Publicado: (2012)

Histamine-Releasing Factor, a New Therapeutic Target in Allergic Diseases
por: Kawakami, Yu, et al.
Publicado: (2019)

Asthma control in adolescents: role of leukotriene inhibitors
por: Giavi, Stavroula, et al.
Publicado: (2010)

The Role of Leukotriene Receptor Signaling in Inflammation and Cancer
por: Massoumi, Ramin, et al.
Publicado: (2007)

Evaluation of Cysteinyl Leukotriene Signaling as a Therapeutic Target for Colorectal Cancer
por: Burke, Lorraine, et al.
Publicado: (2016)

The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic
por: Aigner, Ludwig, et al.
Publicado: (2020)

Therapeutic Targets in Allergic Conjunctivitis
por: Labib, Bisant A., et al.
Publicado: (2022)

Therapeutical Targets in Allergic Inflammation
por: Salvati, Lorenzo, et al.
Publicado: (2022)

Update on leukotriene receptor antagonists in preschool children wheezing disorders
por: Montella, Silvia, et al.
Publicado: (2012)

Cysteinyl–leukotriene and prostaglandin pathways in bronchial versus alveolar lavage in allergic asthmatics
por: van der Burg, Nicole, et al.
Publicado: (2022)

Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases
por: Colazzo, Francesca, et al.
Publicado: (2017)

Cysteinyl Leukotriene Pathway and Cancer
por: Tsai, Ming-Ju, et al.
Publicado: (2021)

Leukotrienes in Atherosclerosis: New Target Insights and Future Therapy Perspectives
por: Riccioni, Graziano, et al.
Publicado: (2009)

Prostaglandins, Leukotrienes, and the Immune Response
por: Ratcliff, Brad
Publicado: (1989)

Leukotrienes as Modifiers of Preclinical Atherosclerosis?
por: Riccioni, Graziano, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8al1pi39mc62j8u0oaj3glcdli